Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism IL1RAP inhibitors(Interleukin-1 receptor accessory protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adult Acute Myeloblastic Leukemia | Preclinical | US | Boston Pharmaceuticals, Inc.Startup | 25 May 2023 |
Adult Acute Myeloblastic Leukemia | Preclinical | CN | 25 May 2023 |